KYVERNA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$5.67
-3.08%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-13.0%
3 months
-24.5%
6 months
-36.1%
1 year
-16.0%
Year to date
-39.7%
52-week range
$5.27 – $11.25
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$350.7M
P/E
-2.3
P/B
2.1
P/S
—
Revenue
$0
Net income
-$152.64M
Diluted EPS
-2.93
Gross margin
—
Net margin
—
Return on equity
-81.90%
Total debt
$33M
Cash
$32.36M
Free cash flow
-$160.16M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$38.32M | — | — | -$40.85M |
| Mar 31, 2026 | $0 | -$39.73M | — | — | -$41.6M |
| Dec 31, 2025 | $0 | -$37.8M | — | — | -$34.06M |
| Sep 30, 2025 | $0 | -$36.79M | — | — | -$43.64M |
| Jun 30, 2025 | $0 | -$42.08M | — | — | -$32.15M |
| Mar 31, 2025 | $0 | -$44.64M | — | — | -$44.92M |
| Dec 31, 2024 | $0 | -$37.49M | — | — | -$37.59M |
| Sep 30, 2024 | $0 | -$34.49M | — | — | -$27.59M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent KYTX news
All market newsNo ticker-linked stories are in the current archive.